By www.marketscagr.com
Global Myotonic Muscular Dystrophy (DMD) Treatments Key Trends And Opportunities To 2031 Story
174
$ 6600
Myotonic Muscular Dystrophy (DMD) Treatments Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Pfizer, Inc. Eli Lilly and Company Mylan Pharmaceuticals Inc. Wockhardt Ltd. Teva Pharmaceutical Industries Ltd. Novartis AG BioMarin Pharmaceutical, Inc. Asklepios Kliniken GmbH Hoveround Corporation Siemens Healthcare